PharmEasy news
PharmEasy appears in 3 stories we have published between August 2026 and October 2026, mostly in our Business and Technology coverage. It is most often reported alongside API Holdings, Apollo 24/7 and Ascent.
Latest development
Netmeds reports flat revenue growth of 2.3% in FY26, maintains profitability
Netmeds, the Reliance-backed online pharmacy platform, reported operating revenue of Rs 44.7 crore for FY26, a marginal increase of 2.3% compared to the previous year. The company remained profitable at Rs 5.5 crore, though profitability declined by 5%, reflecting rising costs and competitive pressures in India’s healthcare sector.
1 October 2026
Covered alongside
%2Fentrackr%2Fmedia%2Fmedia_files%2F2026%2F09%2F30%2Fnetmends-2026-09-30-13-53-10.png&w=3840&q=75)
Netmeds reports flat revenue growth of 2.3% in FY26, maintains profitability
Netmeds reported Rs 44.7 crore in operating revenue for FY26, with marginal growth and a 5% decline in profitability. See how it compares to rivals like Tata 1mg and PharmEasy.
PharmEasy 2026: Comprehensive Company Profile & Overview
Discover PharmEasy 2026: an in-depth company profile & overview. Learn about its financial highlights, funding rounds, and growth trajectory.
Mumbai healthtech funding falls 31% in H1 2026 as large rounds shrink
Inc42 reports Mumbai healthtech startups raised $587 Mn across 60 deals in H1 2026, down 31% YoY, as India’s $5.2 Bn total slipped 9%.